E-Cigarette Use Patterns and High-Risk Behaviors in Pregnancy: Behavioral Risk Factor Surveillance System, 2016-2018.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
08 2020
Historique:
received: 25 11 2019
revised: 26 02 2020
accepted: 27 02 2020
pubmed: 5 5 2020
medline: 16 6 2021
entrez: 5 5 2020
Statut: ppublish

Résumé

The prevalence of e-cigarette use has increased dramatically in the last decade in the U.S. Understanding the prevalence, patterns of use, and risk factor associations of e-cigarette use in pregnant women is particularly important, as this could have potential health implications for the mother and the developing child. Using Behavioral Risk Factor Surveillance System Survey data from 2016 to 2018, adult women of reproductive age (18-49 years) who reported being pregnant (n=7,434) were studied. Self-reported current e-cigarette use was the main exposure. Other measures included combustible cigarette smoking status and high-risk behaviors (including other tobacco, marijuana, or heavy alcohol use; binge drinking; and others). All analyses were done in 2019. Approximately 2.2% of pregnant women reported current e-cigarette use, of whom 0.6% reported daily use. The highest prevalence of e-cigarette use was observed in the youngest age group of pregnant women (3.2%), with 41.7% of all pregnant current e-cigarette users being aged 18-24 years. There was a marked increase in the prevalence of current use of e-cigarettes among pregnant women from 1.9% in 2016 to 3.8% in 2018. Approximately 46% of pregnant current e-cigarette users reported concomitant cigarette smoking. Compared with pregnant never e-cigarette users, pregnant current e-cigarette users had a higher prevalence of other tobacco product use, marijuana use, heavy alcohol intake, binge drinking, and other high-risk behaviors. These findings underscore the need to strengthen prevention and policy efforts, specifically in the vulnerable subgroup of pregnant women.

Identifiants

pubmed: 32362509
pii: S0749-3797(20)30131-8
doi: 10.1016/j.amepre.2020.02.015
pmc: PMC8349302
mid: NIHMS1727804
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-195

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL154130
Pays : United States
Organisme : NHLBI NIH HHS
ID : P50 HL120163
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL120163
Pays : United States

Informations de copyright

Copyright © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Références

BMC Pregnancy Childbirth. 2018 Jun 15;18(1):233
pubmed: 29902987
Ann Intern Med. 2018 Oct 2;169(7):429-438
pubmed: 30167658
Environ Health Perspect. 2018 Feb 21;126(2):027010
pubmed: 29467105
JAMA Intern Med. 2020 Feb 1;180(2):313-314
pubmed: 31609399
Natl Vital Stat Rep. 2018 Nov;67(8):1-50
pubmed: 30707672
Public Health Rep. 2018 Nov;133(6):644-649
pubmed: 30278153
J Obstet Gynecol Neonatal Nurs. 2016 May-Jun;45(3):320-5
pubmed: 27083420
Tob Control. 2019 Nov;28(6):623-628
pubmed: 30733312
BMC Public Health. 2019 Jul 18;19(1):964
pubmed: 31319846
Obstet Gynecol. 2017 Oct;130(4):1
pubmed: 28937568
Pediatrics. 2017 Feb;139(2):
pubmed: 28115539
MMWR Morb Mortal Wkly Rep. 2019 Apr 26;68(16):365-368
pubmed: 31022164
Am J Prev Med. 1999 Apr;16(3):208-15
pubmed: 10198660
Birth Defects Res. 2019 Oct 15;111(17):1294-1301
pubmed: 31400084
MMWR Morb Mortal Wkly Rep. 2019 Mar 01;68(8):189-194
pubmed: 30817748
JAMA Pediatr. 2019 Jun 1;173(6):600-602
pubmed: 31034001
Tob Induc Dis. 2019 Jun 06;17:50
pubmed: 31516493
Nicotine Tob Res. 2015 Oct;17(10):1195-202
pubmed: 25381306
Prev Med. 2018 Dec;117:61-68
pubmed: 29559222
Hellenic J Cardiol. 2019 Jan - Feb;60(1):11-15
pubmed: 30296484
Health Educ Res. 2017 Feb 1;32(1):22-32
pubmed: 28158490
Nicotine Tob Res. 2017 May 1;19(5):585-590
pubmed: 28403454
Am J Prev Med. 2008 Oct;35(4):327-33
pubmed: 18779027
Addict Behav. 2017 Oct;73:151-157
pubmed: 28521240
Obstet Gynecol Surv. 2018 Sep;73(9):544-549
pubmed: 30265741
Nurs Res. 2016 Sep-Oct;65(5):408-14
pubmed: 27579508
Matern Child Health J. 2017 Aug;21(8):1655-1661
pubmed: 28084577
Pediatr Res. 2012 Feb;71(2):215-9
pubmed: 22258135
PLoS One. 2013 Oct 24;8(10):e79332
pubmed: 24250756
Toxics. 2018 Aug 01;6(3):
pubmed: 30071638
Am J Respir Crit Care Med. 2016 Mar 1;193(5):486-94
pubmed: 26756937
Ann N Y Acad Sci. 2015 Mar;1340:65-74
pubmed: 25557889
Prev Med Rep. 2016 Sep 07;4:481-5
pubmed: 27635381
Acta Paediatr. 2008 Oct;97(10):1331-7
pubmed: 18554275
Drug Alcohol Depend. 2018 Oct 1;191:25-36
pubmed: 30077053
Am J Respir Crit Care Med. 2001 Sep 15;164(6):989-94
pubmed: 11587984
Tob Control. 2018 May;27(3):325-333
pubmed: 28596276
J Transl Med. 2015 Oct 15;13:327
pubmed: 26472248
Addict Behav. 2015 Sep;48:79-88
pubmed: 26042613
N Engl J Med. 2019 Feb 14;380(7):689-690
pubmed: 30699300
J Addict Med. 2015 Jul-Aug;9(4):266-72
pubmed: 25974378
JAMA. 2018 May 15;319(19):2039-2041
pubmed: 29800201
BMJ Open. 2016 Apr 05;6(4):e009986
pubmed: 27048634
Prev Med. 2018 Dec;117:52-60
pubmed: 30145348
Subst Use Misuse. 2015 Jan;50(1):79-89
pubmed: 25268294
Public Health Nurs. 2017 Sep;34(5):430-436
pubmed: 28485553
JAMA Pediatr. 2014 Jul;168(7):610-7
pubmed: 24604023
Prev Med. 2015 May;74:59-62
pubmed: 25770433

Auteurs

Olufunmilayo H Obisesan (OH)

Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland; American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas.

Albert D Osei (AD)

Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland; American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas.

S M Iftekhar Uddin (SMI)

Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland; American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas.

Omar Dzaye (O)

Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Radiology and Neuroradiology, Charité, Berlin, Germany.

Miguel Cainzos-Achirica (M)

Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland.

Mohammadhassan Mirbolouk (M)

Department of Medicine, Yale New Haven Hospital, New Haven, Connecticut.

Olusola A Orimoloye (OA)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Garima Sharma (G)

Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland.

Mahmoud Al Rifai (M)

Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.

Andrew Stokes (A)

American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Department of Global Health, Boston University, Boston, Massachusetts.

Aruni Bhatnagar (A)

American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Department of Medicine, University of Louisville, Louisville, Kentucky.

Omar El Shahawy (O)

American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Section on Tobacco, Alcohol and Drug Use, Department of Population Health, School of Medicine, New York University, New York, New York; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.

Emelia J Benjamin (EJ)

American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Department of Medicine, Boston University, Boston, Massachusetts.

Andrew P DeFilippis (AP)

American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Department of Medicine, University of Louisville, Louisville, Kentucky.

Michael J Blaha (MJ)

Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland; American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas. Electronic address: mblaha1@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH